RENEE D GALA Insider Trading $TBPH Theravance Biopharma, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RENEE D GALA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RENEE D GALA. RENEE D GALA is Director in CORCEPT THERAPEUTICS INC ($CORT) and EVP & CFO in Jazz Pharmaceuticals plc ($JAZZ) and SVP, Chief Financial Officer in Theravance Biopharma, Inc. ($TBPH) and SVP-Finance in Theravance Biopharma, Inc. ($TBPH) and VP-Finance in Theravance Biopharma, Inc. ($TBPH) and Director in Gossamer Bio, Inc. ($GOSS).
RENEE D GALA in Theravance Biopharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RENEE D GALA: SVP, Chief Financial Officer, SVP-Finance, VP-Finance
Holdings: 157,657 shares
Current Value: $4,824,304
Latest Transaction: Nov 21 2018
$TBPH Market Capitalization: $1.64B
$TBPH Previous Close: $30.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of RENEE D GALA in Theravance Biopharma, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CORT, GOSS, JAZZ, TBPH
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 21 2018 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 24.79 | 6,697 | 166,019 | 157,657 | 164.4 K to 157.7 K (-4.07 %) |
| Aug 22 2018 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 26.95 | 6,695 | 180,430 | 164,354 | 171 K to 164.4 K (-3.91 %) |
| Aug 16 2018 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Sell | S | 27.43 | 1,700 | 46,623 | 171,049 | 172.7 K to 171 K (-0.98 %) |
| Aug 16 2018 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Sell | S | 26.71 | 39,839 | 1,064,032 | 172,749 | 212.6 K to 172.7 K (-18.74 %) |
| Aug 16 2018 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Sell | S | 27.74 | 2,204 | 61,136 | 212,588 | 214.8 K to 212.6 K (-1.03 %) |
| May 22 2018 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 24.31 | 21,230 | 516,101 | 214,792 | 236 K to 214.8 K (-8.99 %) |
| May 22 2018 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Sell | S | 24.29 | 10,000 | 242,877 | 236,022 | 246 K to 236 K (-4.06 %) |
| May 16 2018 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Grant | A | 0.00 | 33,750 | 0 | 246,022 | 212.3 K to 246 K (+15.90 %) |
| Feb 22 2018 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 29.09 | 5,387 | 156,708 | 211,407 | 216.8 K to 211.4 K (-2.48 %) |
| Nov 22 2017 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 28.58 | 6,753 | 193,001 | 207,794 | 214.5 K to 207.8 K (-3.15 %) |
| Aug 22 2017 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 27.40 | 6,752 | 185,005 | 214,547 | 221.3 K to 214.5 K (-3.05 %) |
| May 23 2017 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 36.83 | 6,753 | 248,713 | 221,299 | 228.1 K to 221.3 K (-2.96 %) |
| Feb 22 2017 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 33.78 | 10,211 | 344,928 | 226,350 | 236.6 K to 226.4 K (-4.32 %) |
| Feb 08 2017 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Grant | A | 0.00 | 9,000 | 0 | 236,561 | 227.6 K to 236.6 K (+3.95 %) |
| Nov 22 2016 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 31.96 | 4,628 | 147,911 | 227,561 | 232.2 K to 227.6 K (-1.99 %) |
| Aug 23 2016 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 27.89 | 4,306 | 120,094 | 232,189 | 236.5 K to 232.2 K (-1.82 %) |
| May 24 2016 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 20.55 | 3,333 | 68,493 | 236,495 | 239.8 K to 236.5 K (-1.39 %) |
| Mar 17 2016 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Grant | A | 0.00 | 90,000 | 0 | 238,125 | 148.1 K to 238.1 K (+60.76 %) |
| Feb 23 2016 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 15.65 | 13,052 | 204,264 | 148,125 | 161.2 K to 148.1 K (-8.10 %) |
| Aug 17 2015 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Buy | P | 12.16 | 5,000 | 60,800 | 161,177 | 156.2 K to 161.2 K (+3.20 %) |
| Aug 17 2015 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Buy | P | 12.19 | 5,000 | 60,950 | 154,279 | 149.3 K to 154.3 K (+3.35 %) |
| Feb 09 2015 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Grant | A | 0.00 | 135,000 | 0 | 149,279 | 14.3 K to 149.3 K (+945.44 %) |
| Aug 22 2014 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP-Finance | Payment of Exercise | F | 26.98 | 158 | 4,263 | 14,279 | 14.4 K to 14.3 K (-1.09 %) |
| Jul 23 2014 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP-Finance | Option Exercise | A | 32.13 | 85,000 | 2,731,050 | 85,000 | |
| Jun 05 2014 | TBPH | Theravance Biophar ... | GALA RENEE D | VP-Finance | Option Exercise | A | 23.51 | 85,000 | 1,998,350 | 85,000 |
Page: 1